thiodipropionic acid has been researched along with B16 Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, H; Ge, Y; Li, L; Yang, M; Zhu, Y | 1 |
1 other study(ies) available for thiodipropionic acid and B16 Melanoma
| Article | Year |
|---|---|
Co-delivery of paclitaxel and doxorubicin using mixed micelles based on the redox sensitive prodrugs.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Disulfides; Doxorubicin; Drug Delivery Systems; Drug Liberation; Female; Melanoma, Experimental; Mice; Micelles; Oxidation-Reduction; Paclitaxel; Prodrugs; Propionates; Tumor Burden; Vitamin E | 2019 |